These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
454 related items for PubMed ID: 18726190
1. Lupulone, a hop bitter acid, activates different death pathways involving apoptotic TRAIL-receptors, in human colon tumor cells and in their derived metastatic cells. Lamy V, Roussi S, Chaabi M, Gossé F, Lobstein A, Raul F. Apoptosis; 2008 Oct; 13(10):1232-42. PubMed ID: 18726190 [Abstract] [Full Text] [Related]
2. Chemopreventive effects of lupulone, a hop {beta}-acid, on human colon cancer-derived metastatic SW620 cells and in a rat model of colon carcinogenesis. Lamy V, Roussi S, Chaabi M, Gossé F, Schall N, Lobstein A, Raul F. Carcinogenesis; 2007 Jul; 28(7):1575-81. PubMed ID: 17434926 [Abstract] [Full Text] [Related]
3. Silibinin triggers apoptotic signaling pathways and autophagic survival response in human colon adenocarcinoma cells and their derived metastatic cells. Kauntz H, Bousserouel S, Gossé F, Raul F. Apoptosis; 2011 Oct; 16(10):1042-53. PubMed ID: 21779837 [Abstract] [Full Text] [Related]
4. Lupulone triggers p38 MAPK-controlled activation of p53 and of the TRAIL receptor apoptotic pathway in human colon cancer-derived metastatic cells. Lamy V, Bousserouel S, Gossé F, Minker C, Lobstein A, Raul F. Oncol Rep; 2011 Jul; 26(1):109-14. PubMed ID: 21519792 [Abstract] [Full Text] [Related]
5. A mitochondrial block and expression of XIAP lead to resistance to TRAIL-induced apoptosis during progression to metastasis of a colon carcinoma. Ndozangue-Touriguine O, Sebbagh M, Mérino D, Micheau O, Bertoglio J, Bréard J. Oncogene; 2008 Oct 09; 27(46):6012-22. PubMed ID: 18560353 [Abstract] [Full Text] [Related]
6. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5. Park SJ, Wu CH, Choi MR, Najafi F, Emami A, Safa AR. Biochem Pharmacol; 2006 Jul 28; 72(3):293-307. PubMed ID: 16753135 [Abstract] [Full Text] [Related]
7. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation. Hamaï A, Richon C, Meslin F, Faure F, Kauffmann A, Lecluse Y, Jalil A, Larue L, Avril MF, Chouaib S, Mehrpour M. Oncogene; 2006 Dec 07; 25(58):7618-34. PubMed ID: 16983347 [Abstract] [Full Text] [Related]
8. Reactive oxygen species regulate caspase activation in tumor necrosis factor-related apoptosis-inducing ligand-resistant human colon carcinoma cell lines. Izeradjene K, Douglas L, Tillman DM, Delaney AB, Houghton JA. Cancer Res; 2005 Aug 15; 65(16):7436-45. PubMed ID: 16103097 [Abstract] [Full Text] [Related]
9. The flavonolignan silibinin potentiates TRAIL-induced apoptosis in human colon adenocarcinoma and in derived TRAIL-resistant metastatic cells. Kauntz H, Bousserouel S, Gossé F, Raul F. Apoptosis; 2012 Aug 15; 17(8):797-809. PubMed ID: 22555452 [Abstract] [Full Text] [Related]
10. Phytosphingosine in combination with TRAIL sensitizes cancer cells to TRAIL through synergistic up-regulation of DR4 and DR5. Choi SY, Kim MJ, Chung HY, Lee SJ, Jang YJ. Oncol Rep; 2007 Jan 15; 17(1):175-84. PubMed ID: 17143496 [Abstract] [Full Text] [Related]
11. Caspase-dependent molecular mechanisms of anti-human DR5 monoclonal antibody mDRA-6 inducing apoptosis of human leukemia Jurkat cells. Du YW, Liu GC, Wang J, Zhao YP, Li SL, Chen JG, Jiang Q, Cai J, Ma YF. Ai Zheng; 2009 Feb 15; 28(2):112-6. PubMed ID: 19550122 [Abstract] [Full Text] [Related]
12. Mitochondria from TRAIL-resistant prostate cancer cells are capable of responding to apoptotic stimuli. Liang Y, Eid MA, Lewis RW, Kumar MV. Cell Signal; 2005 Feb 15; 17(2):243-51. PubMed ID: 15494215 [Abstract] [Full Text] [Related]
13. Baicalein overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance via two different cell-specific pathways in cancer cells but not in normal cells. Taniguchi H, Yoshida T, Horinaka M, Yasuda T, Goda AE, Konishi M, Wakada M, Kataoka K, Yoshikawa T, Sakai T. Cancer Res; 2008 Nov 01; 68(21):8918-27. PubMed ID: 18974136 [Abstract] [Full Text] [Related]
14. Targeting pro-apoptotic trail receptors sensitizes HeLa cervical cancer cells to irradiation-induced apoptosis. Maduro JH, de Vries EG, Meersma GJ, Hougardy BM, van der Zee AG, de Jong S. Int J Radiat Oncol Biol Phys; 2008 Oct 01; 72(2):543-52. PubMed ID: 18793956 [Abstract] [Full Text] [Related]
15. TRAIL resistance of breast cancer cells is associated with constitutive endocytosis of death receptors 4 and 5. Zhang Y, Zhang B. Mol Cancer Res; 2008 Dec 01; 6(12):1861-71. PubMed ID: 19074831 [Abstract] [Full Text] [Related]
16. DR5 receptor mediates anoikis in human colorectal carcinoma cell lines. Laguinge LM, Samara RN, Wang W, El-Deiry WS, Corner G, Augenlicht L, Mishra L, Jessup JM. Cancer Res; 2008 Feb 01; 68(3):909-17. PubMed ID: 18245494 [Abstract] [Full Text] [Related]
17. Combined treatment with Ad-hTRAIL and DTIC or SAHA is associated with increased mitochondrial-mediated apoptosis in human melanoma cell lines. Lillehammer T, Engesaeter BO, Prasmickaite L, Maelandsmo GM, Fodstad O, Engebraaten O. J Gene Med; 2007 Jun 01; 9(6):440-51. PubMed ID: 17410615 [Abstract] [Full Text] [Related]
18. Modification of gene products involved in resistance to apoptosis in metastatic colon cancer cells: roles of Fas, Apaf-1, NFkappaB, IAPs, Smac/DIABLO, and AIF. Huerta S, Heinzerling JH, Anguiano-Hernandez YM, Huerta-Yepez S, Lin J, Chen D, Bonavida B, Livingston EH. J Surg Res; 2007 Sep 01; 142(1):184-94. PubMed ID: 17603079 [Abstract] [Full Text] [Related]
19. Apple procyanidins activate apoptotic signaling pathway in human colon adenocarcinoma cells by a lipid-raft independent mechanism. Maldonado-Celis ME, Bousserouel S, Gossé F, Lobstein A, Raul F. Biochem Biophys Res Commun; 2009 Oct 16; 388(2):372-6. PubMed ID: 19666002 [Abstract] [Full Text] [Related]
20. Effect of hyperthermia on TRAIL-induced apoptotic death in human colon cancer cells: development of a novel strategy for regional therapy. Yoo J, Lee YJ. J Cell Biochem; 2007 Jun 01; 101(3):619-30. PubMed ID: 17212362 [Abstract] [Full Text] [Related] Page: [Next] [New Search]